A multicenter, comparative, randomized, double-blind, placebo controlled study on the effect on weight of adjunctive treatment with aripiprazole in patients with schizophrenia.

Trial Profile

A multicenter, comparative, randomized, double-blind, placebo controlled study on the effect on weight of adjunctive treatment with aripiprazole in patients with schizophrenia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Nov 2013

At a glance

  • Drugs Aripiprazole (Primary)
  • Indications Schizophrenia
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 23 Sep 2010 Actual end date changed from Jun 2007 to Dec 2007 as reported by ClinicalTrials.gov.
    • 03 Sep 2008 Results presented at ECNP 2008.
    • 08 Nov 2007 The expected completion date for this trial is now 1 Jun 2007.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top